| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |